Hexo Corp (TSE:HEXO) has been assigned a consensus rating of “Buy” from the eight ratings firms that are covering the stock, Marketbeat reports. Four research analysts have rated the stock with a buy recommendation. The average twelve-month price objective among analysts that have updated their coverage on the stock in the last year is C$9.46.
Separately, CIBC cut their price objective on shares of Hexo from C$8.50 to C$7.50 in a research report on Friday, October 4th.
The business’s fifty day moving average price is C$5.92. The company has a debt-to-equity ratio of 7.80, a current ratio of 5.62 and a quick ratio of 4.05. The firm has a market cap of $1.46 billion and a price-to-earnings ratio of -27.42. Hexo has a 52-week low of C$4.11 and a 52-week high of C$11.29.
Hexo Company Profile
HEXO Corp., through its subsidiary, HEXO Operations Inc, produces, markets, and sells cannabis in Canada. The company offers dried cannabis under the Time of Day and H2 lines; Elixir, a cannabis oil sublingual mist product line; and Decarb, an activated fine-milled cannabis powder product. It provides its products under the HEXO and Hydropothecary brand names.
Featured Story: Support Level
Receive News & Ratings for Hexo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hexo and related companies with MarketBeat.com's FREE daily email newsletter.